SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta is surging as investors react to reports of a new cloud initiative to monetize excess AI compute capacity, shifting sentiment from concerns over runaway capital expenditure toward potential revenue-generating optionality. The community is actively debating whether this signals a strategic pivot into a viable hyperscaler-style business model or reflects underlying inefficiency and overbuilding in the company's AI infrastructure.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Cloud Memory Business Unit (CMBU), Core Data Center Business Unit (CDBU), Mobile and Client Business Unit (MCBU), and Automotive and Embedded Business Unit (AEBU). The CMBU segment focuses on memory solutions for large hyperscale cloud customers and High-Bandwidth Memory for all data center customers. The CDBU segment is involved in memory solutions for mid-tier cloud, enterprise, and OEM data center customers and storage solutions for all data center customers. The MCBU segment focuses on memory and storage solutions for the mobile and client segments. The AEBU segment is involved in memory and storage solutions for the automotive, industrial, and consumer segments. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron Technology is experiencing sharp volatility as investors digest reports of potential excess compute capacity in the AI ecosystem and broader sector rotation, leading to a significant pullback from recent highs. While some market participants are expressing concern over high-level valuation and short-term news catalysts, a vocal segment of the community remains focused on strong long-term fundamentals, persistent memory shortages, and strategic supply agreements as reasons to treat the decline as an accumulation opportunity.

Jack in the Box, Inc. engages in the provision of developing, operating, and franchising a chain of quick-service and fast-casual restaurants. It operates through the Jack in the Box and Del Taco segments. The Jack in the Box segment offers a selection of distinctive products including classic burgers and other product lines such as Buttery Jack Burgers. The company was founded by Robert Oscar Peterson in 1951 and is headquartered in San Diego, CA.

Jack In The Box, Inc.

Jack in the Box is trending as retail traders target the stock for a potential short squeeze, citing its significantly small float and high short interest as key drivers for volatility. The community is actively comparing the setup to past high-profile squeeze plays, fueling intense debate over whether the company's turnaround plan and debt refinancing efforts will fuel a rally or if the bearish sentiment will prevail.

Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. It operates through the following segments: Teladoc Health Integrated Care, BetterHelp, and Others. The Teladoc Health Integrated Care segment offers virtual medical services. The BetterHelp segment includes virtual mental health and other wellness services. The company was founded in June 2002 by George Byron Brooks, Michael Gorton, and Gary Wald and is headquartered in New York, NY.

Teladoc Health Inc

Teladoc Health is trending as the community debates its long-term potential as a digital healthcare infrastructure leader, following a strategic partnership with Walmart to integrate virtual services into the retailer's platform. Investors are closely monitoring high short interest and institutional accumulation, with many discussing the stock's potential for a major rerating if management successfully navigates its ongoing turnaround and margin expansion efforts.

SoundHound AI, Inc. engages in the development, owning, and commercialization of voice, sound, and natural language artificial intelligence technologies and related activities. The company was founded by Keyvan Mohajer, Majid Seyed Emami and James M. Hom on September 2, 2005 and is headquartered in Santa Clara, CA.

SoundHound AI Inc - Ordinary Shares - Class A

SoundHound AI Inc

SoundHound AI is experiencing heightened community interest driven by high short interest and technical setups that many retail investors believe could trigger a significant short squeeze. Market participants are actively discussing the stock's potential for a reversal while closely monitoring enterprise adoption, upcoming earnings, and potential acquisition speculation as key catalysts for future price momentum.

Direxion Shares ETF Trust - Direxion Daily MSCI South Korea Bull 3X ETF

Direxion Daily South Korea Bull 3X Shares

KORU is trending as retail and institutional investors navigate extreme volatility driven by Samsung union strike threats and aggressive rebalancing by the South Korean National Pension Service. The community is actively debating whether these sharp pullbacks represent a structural end to the memory chip rally or merely an artificial discount buying opportunity for a sector expected to face supply shortages through 2028.

DraftKings, Inc. is a digital sports entertainment and gaming company, which engages in the provision of online sports betting, online casino, daily fantasy sports product offerings, DraftKings Marketplace, retail sportsbook, media, and other consumer product offerings. The company was founded by Jason D. Robins, Matthew Kalish, and Paul Liberman on December 31, 2011 and is headquartered in Boston, MA.

DraftKings Inc. - Ordinary Shares - Class A

DraftKings Inc

DraftKings is trending as investors digest the launch of its proprietary prediction exchange, DKeX, while weighing the competitive implications of Meta's entry into the prediction market space. Community discussion is sharply divided between bulls highlighting record-breaking World Cup betting handle and institutional backing, and bears expressing frustration over stagnant price action and competitive saturation.

General Mills, Inc. engages in the manufacture of food. Its portfolio of brands includes household names like Cheerios, Nature Valley, Blue Buffalo, Häagen-Dazs, Old El Paso, Pillsbury, Betty Crocker, Totino’s, Annie’s, Wanchai Ferry and more. It operates through the following segments: North America Retail, International, North America Pet, and North America Foodservice. The North America Retail segment includes grocery stores, mass merchandisers, membership stores, natural food chains, drug, dollar and discount chains, convenience stores, and e-commerce grocery providers. The International segment refers to the retail and foodservice businesses outside of the US and Canada. The North America Pet segment includes pet food products sold in national pet superstore chains, e-commerce retailers, grocery stores, regional pet store chains, mass merchandisers, and veterinary clinics and hospitals. The North America Foodservice segment offers ready-to-eat cereals, snacks, refrigerated yogurt, frozen meals, unbaked and fully baked frozen dough products, baking mixes, and bakery flour. The company was founded by Cadwallader C. Washburn on June 20, 1928 and is headquartered in Minneapolis, MN.

General Mills, Inc.

General Mills is trending after slashing its fiscal 2026 outlook due to weaker-than-expected consumer demand, which triggered a significant sell-off in the stock and dragged down the broader consumer staples sector. Community sentiment is deeply divided between long-term investors viewing the pullback as a generational buying opportunity for a dividend-paying blue chip and traders concerned that inflationary pressures, shifting consumer preferences toward private-label goods, and ongoing margin headwinds could signal further downside.

Constellation Energy Corp. engages in the generation, supply, and marketing of clean electricity, and renewable energy products and solutions. The firm also offers wholesale energy, retail products and services. It operates under the following geographical segments: Mid-Atlantic, Midwest, New York, Electric Reliability Council of Texas (ERCOT), and Other Power Regions Segment. The company was founded in 1960 and is headquartered in Baltimore, MD.

Constellation Energy Corporation

Constellation Energy is experiencing significant volatility driven by institutional interest in nuclear power as a long-term solution to AI-driven electricity demands. While the stock has faced downward pressure from a secondary share offering and sector-wide de-risking, community sentiment remains largely bullish, focusing on its massive nuclear fleet, recent long-term power agreements, and its critical role in the expanding AI infrastructure bottleneck.

Aurinia Pharmaceuticals, Inc. is a clinical stage bio-pharmaceutical company, which engages in the research, development, and commercialization of therapeutic drugs. The company was founded by Robert Foster, Richard Glickman, and Michael Martin on June 16, 1993 and is headquartered in Edmonton, Canada.

Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals is facing significant investor frustration as shareholders debate the company's sluggish performance relative to the broader biotech sector and demand clarity regarding management's long-term strategy. The community is actively discussing the lack of immediate catalysts despite recent aggressive share accumulation by CEO Kevin Tang, leading to widespread speculation about potential M&A activity.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

ZETA SURGICAL Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics

ZETA SURGICAL Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics ZETA SURGICAL Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics PR Newswire SARASOTA, Fla, and BOSTON, June 23, 2026 SARASOTA, Fla...

NRx Pharmaceuticals (NRXP) Stock Fell 19% After Hours On Tuesday: Here's Why

NRXP stock fell after hours after NRx Pharmaceuticals announced a public stock offering to raise capital for growth and operations.read more...

NRx Pharmaceuticals, Inc. (NRXP) Reports Q1 Loss, Lags Revenue Estimates

NRx Pharmaceuticals (NRXP) delivered earnings and revenue surprises of +20.00% and -91.28%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?

NRx Pharmaceuticals Earnings Are Imminent; These Most Accurate Analysts Revise Forecasts Ahead Of Earnings Call

NRx Pharma (NRXP) set to release Q1 earnings on May 18. Analysts expect $19.43 million in revenue, with a loss of 11 cents per share. FDA clearance received for clinical trial.read more...

D. Boral Capital Reaffirms Buy Rating for NRx Pharmaceuticals (NASDAQ:NRXP)

D. Boral Capital restated a 'buy' rating and issued a $34.00 price objective on shares of NRx Pharmaceuticals in a research note on Tuesday...

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP) Sees Large Growth in Short Interest

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Get Free Report) was the recipient of a significant growth in short interest during the month of April. As of April 15th, there was short interest totaling...

Equities Analysts Offer Predictions for NRXP Q1 Earnings

NRx Pharmaceuticals, Inc. (NASDAQ:NRXP - Free Report) - Research analysts at HC Wainwright issued their Q1 2027 earnings estimates for NRx Pharmaceuticals in a note issued to investors on Monday...

NRx Pharmaceuticals (NASDAQ:NRXP) Earns "Buy" Rating from HC Wainwright

HC Wainwright reiterated a "buy" rating and set a $45.00 price target on shares of NRx Pharmaceuticals in a report on Monday...

NRx Pharmaceuticals (NASDAQ:NRXP) Price Target Raised to $49.00 at Ascendiant Capital Markets

Ascendiant Capital Markets lifted their price target on shares of NRx Pharmaceuticals from $48.00 to $49.00 and gave the stock a "buy" rating in a research note on Monday...

NRx Pharmaceuticals' (NRXP) Buy Rating Reiterated at D. Boral Capital

D. Boral Capital restated a "buy" rating and set a $34.00 target price on shares of NRx Pharmaceuticals in a research note on Monday...

NRX Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. The company was founded by Jonathan C. Javitt on September 18, 2017 and is headquartered in Wilmington, DE.

NRX Pharmaceuticals Inc

Why Did NRXP Stock Surge 21% Pre-Market Today?

Equity

Neutral Sentiment

Hold rates steady

Cut 25 bps

Hike 25 bps

Fed decision day is here - Kevin Warsh chairs his first FOMC meeting with markets pricing a hold at 3.50%-3.75% but watching for a hawkish shift. Vote on what you expect to be decided today, then drop your prediction for the first rate cut or hike in the comments.

What do you expect the Fed to decide at its FOMC meeting today? 
 
Drop a comment with when you expect the first cut/hike to be.

Current Price	$3.86
Prev Close	$4.09
Open	$4.07
Dividend Yield	0.00%
50-Day Moving Average	$3.55
Beta	1.20
Avg. Volume	1.4M
PE Ratio	-3.02

52-Week High	$5.06
52-Week Low	$1.62
Market Capitalization	$171.55M
EPS (Annual)	-$1.34
Price to Book	-9.35
Revenue Per Employee	N/A

Feed

News

Sentiment

Earnings

Fundamentals

Info

NRXPNRX Pharmaceuticals Inc

Latest NRXP News